IGF2BP2 and colorectal cancer: In patients with colorectal cancer (CRC), METTL3 enhances the stability of hexokinase 2 (HK2) and glucose transporter GLUT1 mRNAs by interacting with their 3′UTR regions, with the stability of HK2 and GLUT1 being mediated by IGF2BP2 and IGF2BP3, respectively.